Combined Hormonal Contraceptives

Key Points

  • Combined hormonal contraceptives (CHCs) contain both estrogen and progestin — they suppress ovulation, thicken cervical mucus, and alter the endometrium to prevent implantation.
  • Available forms: oral pills (COC), transdermal patch (weekly × 3 weeks), and vaginal ring (inserted × 3 weeks).
  • Real-world effectiveness differs from perfect use; oral pills and vaginal ring are commonly around 93 percent effective with typical use because adherence errors are common.
  • Absolute contraindication: smoking + age ≥35 years — significantly increases risk of thromboembolic events, stroke, and MI.
  • Most common side effects: nausea and breakthrough bleeding — usually resolve within 3 months; advise taking pills at bedtime to minimize nausea.
  • ACHES mnemonic — serious warning signs requiring immediate evaluation: Abdominal pain, Chest pain, Headache (severe), Eye changes, Severe leg pain.

Mechanism of Action

Combined hormonal contraceptives exert their effects through three mechanisms:

  1. Primary: Suppression of ovulation — estrogen/progestin feedback inhibits FSH and LH release from the pituitary
  2. Secondary: Thickening of cervical mucus — progestin effect prevents sperm penetration
  3. Tertiary: Alteration of endometrial lining — makes it less favorable for implantation

Drug Forms and Dosing

Combined Oral Contraceptives (COC)

Three types based on hormone dose variation:

TypeDescriptionExamples
MonophasicFixed ratio of estrogen + progestin throughoutAviane (levonorgestrel/ethinyl estradiol 20 mcg/0.1 mg)
BiphasicFixed estrogen + varying progestin doseSeasonique
TriphasicLow doses with varying estrogen and progestinMircette (desogestrel/ethinyl estradiol)
Extended/continuousNo hormone-free intervalIndefinite use — reduces scheduled and breakthrough bleeding

Standard regimen: 21 active hormone pills + 7 inactive (placebo) pills = 28-day cycle

Transdermal Patch

  • Applied to skin (buttocks, upper outer arm, lower abdomen, upper back — not breasts)
  • Changed weekly for 3 weeks, patch-free for 1 week
  • Press firmly for 10 seconds; place on clean, dry skin
  • Contains estrogen-progestin combination

Vaginal Ring (NuvaRing)

  • Flexible ring inserted vaginally; left in place for 3 weeks
  • Removed for 1 week before new ring inserted
  • If ring is removed for >3 hours, use backup contraception for 7 days
  • Reusable 1-year ring: clean and store between cycles

Adverse Effects and Contraindications

Common Adverse Effects

EffectManagement
NauseaTake at bedtime; resolves in ~3 months
Breakthrough bleedingUsually resolves in ~3 months; do not stop pill
Weight changes, fluid retentionExpected hormonal effect
Mood changes, decreased libidoMay require pill change
HeadachesAssess for migraine with aura — contraindication

Serious Adverse Effects (ACHES)

ACHES Warning Signs

Instruct patients to report these immediately:

  • Abdominal pain (severe) — possible hepatic vein thrombosis or ischemia
  • Chest pain — possible pulmonary embolism or MI
  • Headaches (severe/sudden) — possible stroke or cerebral thrombosis
  • Eye changes (blurred vision, double vision, vision loss) — possible retinal thrombosis or stroke
  • Severe leg pain or swelling — possible deep vein thrombosis (DVT)

Contraindications

Absolute ContraindicationsRationale
Smoking + age ≥35 yearsMarkedly increased cardiovascular and thromboembolic risk
History of DVT, PE, or strokeEstrogen further increases clotting risk
Hypertension (uncontrolled)Risk of stroke and MI
Migraine with auraRisk of stroke
Hormone-sensitive breast cancerEstrogen stimulates tumor growth
PregnancyEstrogens cross the placenta
Active liver diseaseEstrogens metabolized by liver

Nursing Assessment

NCLEX Focus

The highest priority contraindication for combined hormonal contraceptives is smoking in women ≥35 years. Teach ACHES warning signs. Side effects (nausea, breakthrough bleeding) are common in the first 3 months — reassure patients and advise against stopping the pill prematurely.

  • Obtain complete history: smoking status, age, personal and family history of blood clots, hypertension, migraines, diabetes, cancer history
  • Assess blood pressure before prescribing — hypertension is a contraindication
  • Review all current medications for interactions (antibiotics, anticonvulsants, rifampin reduce effectiveness)
  • Screen for temporary reduced efficacy contexts (for example, vomiting/diarrhea >48 hours) that may require backup contraception.
  • Confirm no current or planned pregnancy

Nursing Interventions and Patient Education

  • Nausea management: Take pill at bedtime; small, frequent meals; ginger ale; avoid spicy/greasy foods — should resolve in 3 months
  • Starting the pill: “Sunday start” or first-day start — use backup method (condom) for first 7 days if not starting on first day of period
  • Missed pills: 1 missed pill — take as soon as remembered + continue pack; 2+ missed pills — use backup contraception; consult package instructions
  • Drug interactions: Emphasize that rifampin (and selected hepatic enzyme inducers such as certain antiepileptics, HIV therapies, St. John’s wort, griseofulvin) can reduce efficacy; use backup or alternate method as indicated
  • Educate patients that COCs do not protect against sexually transmitted infections (STIs)
  • Teach ACHES warning signs and instruct patient to seek immediate care if any occur
  • Review contraindications before prescribing: smoking ≥35 years, history of clots, migraines with aura, uncontrolled BP

Self-Check

  1. A 38-year-old woman who smokes one pack per day requests a combined oral contraceptive pill. What is the nurse’s response?
  2. A patient calls the clinic reporting nausea after starting the pill 3 days ago and wants to stop. What should the nurse advise?
  3. What does ACHES stand for, and why is each symptom a warning sign with combined hormonal contraceptives?